MedImmune presents data at AAP National Conference & Exhibition demonstrating burden of RSV disease
MedImmune presents four abstracts on the burden of respiratory syncytial virus (RSV) disease among preterm infants, highlighting increased medical costs and morbidity in late-preterm births. The company's research aims to identify new risk factors for RSV hospitalization and evaluate cost implications of expanded prophylaxis.